Media Coverage (Cancers)
Cancers
-
- All Categories
- Brain Health
- Cancers
- Cell Dynamics
- Computational Biology
- COVID-19
- Disease
- Environment
- Experimental
- Healthspan
- Healthy Aging
- Immune System
- Infectious Disease
- Microbiome
- Nobel Prize
- Pregnancy Health
- Proteomics
- Scientific Wellness
Sort
-
- Default
- A-Z
- Z-A
- Newest
- Oldest
Epigenetic Changes Allow Cancer Cells to Shift Identity and Survive Drugs
Researchers from ISB’s Wei and Heath labs show that cancer cells can quickly reprogram themselves in response to treatment, using epigenetic changes to survive drugs — revealing that resistance may begin much earlier than previously understood.
A Lung Cancer that Changes Its Identity May Be Hiding in Plain Sight
ISB’s Dr. Wei Wei contributed to research showing that certain lung cancers can shift identity and exist in hybrid states, helping explain treatment resistance and suggesting new approaches to diagnosis and therapy for these aggressive, often underdiagnosed tumors.
Lee Hood’s Persistent Plan to Reinvent Medicine From the Ground Up
This profile details Lee Hood and his decades-long mission to transform medicine through systems biology and predictive health. Hood outlines how large-scale biological data and longitudinal studies could enable earlier detection of disease and more proactive healthcare.
AI for impact: AWS awards Imagine Grants to pioneering nonprofits across three continents
The Institute for Systems Biology (ISB) has been awarded a 2025 AWS Imagine Grant — funding that will accelerate the development of its generative-AI platform Tarpon, which creates “digital fingerprints” of T-cell receptors, enabling faster discovery and design of targeted immunotherapies.
Molecular biologist Mary Brunkow is the Nobel Prize winner next door
This feature traces the remarkable arc of Mary Brunkow — from undergraduate at the University of Washington to 2025 Nobel Laureate — spotlighting her foundational discovery of the gene FOXP3, and how that breakthrough unlocked a new understanding of immune-system self-tolerance. The story also reflects on the years of basic research, the long-standing impact on immunology, and how Brunkow’s journey connects back to her roots in Seattle’s scientific community.
A conversation with UW alum and Nobel Prize winner Mary Brunkow
University of Washington alum Mary Brunkow has been awarded the 2025 Nobel Prize in Physiology or Medicine for pioneering research into how the immune system is prevented from attacking the body’s own tissues – work that has profound implications for autoimmune disease, cancer therapies, and transplant medicine.
Here are this year’s Nobel Prize award laureates and how they shifted the world’s perception of immune response
Explained PH includes ISB’s Dr. Mary Brunkow among the 2025 Nobel laureates whose discoveries revolutionized our understanding of the immune system. (Note – minor editorial inconsistencies included in original text.)
Nobel Prize lessons –The immune system’s security guards
The Nobel Prize organization has published an educational resource to help teachers introduce students to the 2025 Nobel Prize in Physiology or Medicine, highlighting the discoveries of Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi in immune tolerance.
Nobel Laureate Dr. Mary Brunkow speaks at a press conference held at ISB on October 7, 2025. (Photo by Alex Garland for ISB)
ISB’s 2025 Nobel Prize Coverage
ISB’s Dr. Mary Brunkow received the 2025 Nobel Prize in Physiology or Medicine for transformative discoveries in immune tolerance.
Visit our Nobel Prize hub page for stories, photos, reactions celebrating this historic achievement, and more.